Associated Papers
Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance.
Delviks-Frankenberry KA et al.
Virology, 2013
Connection domain mutations in treatment-experienced patients in the OPTIMA trial.
Dau B et al.
Journal of Acquired Immune Deficiency Syndromes (1999), 2010
Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistance.
Nikolenko GN et al.
Proceedings of the National Academy of Sciences of the United States of America, 2007
Select a paper to view details